Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer

NCT06431685 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

NSCLC
Low Dose Radiotherapy
PD-1 Inhibitor
Leptomeningeal Metastasis

Interventions

RADIATION: Whole Brain Low Dose Radiotherapy
DRUG: Pemetrexed
DRUG: Sintilimab
DRUG: Chemotherapy

Sponsor

Sichuan University